JPMorgan Chase & Co’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13
| Closed | -$50 | – | 6626 |
|
|
2024
Q3 | $50 | Hold |
13
| – | – | ﹤0.01% | 6053 |
|
|
2024
Q2 | $30 | Sell |
13
-28
| -68% | -$65 | ﹤0.01% | 6089 |
|
|
2024
Q1 | $116 | Buy |
41
+3
| +8% | +$8 | ﹤0.01% | 5868 |
|
|
2023
Q4 | $119 | Buy |
38
+3
| +9% | +$9 | ﹤0.01% | 6063 |
|
|
2023
Q3 | $116 | Buy |
35
+15
| +75% | +$50 | ﹤0.01% | 5935 |
|
|
2023
Q2 | $66 | Hold |
20
| – | – | ﹤0.01% | 5818 |
|
|
2023
Q1 | $0 | Hold |
20
| – | – | ﹤0.01% | 6183 |
|
|
2022
Q4 | $0 | Sell |
20
-9
| -31% | – | ﹤0.01% | 6013 |
|
|
2022
Q3 | $0 | Buy |
+29
| New | – | ﹤0.01% | 5891 |
|
|
2021
Q1 | – | Sell |
-10
| Closed | – | – | 5415 |
|
|
2020
Q4 | $0 | Buy |
+10
| New | – | ﹤0.01% | 5139 |
|
|
2019
Q3 | – | Sell |
-295
| Closed | -$4K | – | 4937 |
|
|
2019
Q2 | $4K | Sell |
295
-29,674
| -99% | -$402K | ﹤0.01% | 4729 |
|
|
2019
Q1 | $521K | Sell |
29,969
-75,642
| -72% | -$1.32M | ﹤0.01% | 3359 |
|
|
2018
Q4 | $1.44M | Sell |
105,611
-22,930
| -18% | -$314K | ﹤0.01% | 2835 |
|
|
2018
Q3 | $2.77M | Buy |
128,541
+76,850
| +149% | +$1.65M | ﹤0.01% | 2613 |
|
|
2018
Q2 | $2.22M | Sell |
51,691
-3,128
| -6% | -$134K | ﹤0.01% | 2752 |
|
|
2018
Q1 | $3.58M | Buy |
54,819
+54,022
| +6,778% | +$3.52M | ﹤0.01% | 2415 |
|
|
2017
Q4 | $58K | Buy |
797
+725
| +1,007% | +$52.8K | ﹤0.01% | 4088 |
|
|
2017
Q3 | $6K | Buy |
72
+10
| +16% | +$833 | ﹤0.01% | 4114 |
|
|
2017
Q2 | $4K | Sell |
62
-79
| -56% | -$5.1K | ﹤0.01% | 4174 |
|
|
2017
Q1 | $30K | Buy |
141
+94
| +200% | +$20K | ﹤0.01% | 4038 |
|
|
2016
Q4 | $4K | Buy |
+47
| New | +$4K | ﹤0.01% | 4345 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | – | – | 4306 |
|
|
2015
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4140 |
|